thinking about antibody validation
DESCRIPTION
Addressing the growing concerns associated with the use of commercial antibodies in research and in diagnostics.TRANSCRIPT
@StJohnsLabs
www.stjohnslabs.com
A Standard for
Antibody Validation !
There is no governing agency
monitoring what can be
sold in the antibody based
assay market.
What is the end
goal?
•High standards for antibody validation
•Greater confidence
•Eliminate wasted time and money
• Incentive to validate
EVERYONESuppliers
Distributors Laboratory directors
Scientists
Find out in Part Two.
1. Bordeaux J, Welsh A, Agarwal S, Killiam E, Baquero M, Hanna J, Anagnostou V, Rimm D. Antibody validation. Biotechniques. 2010 Mar;48(3):197-209.
2. Welsh AW, Lannin DR, Young GS, Sherman ME, Figueroa JD, Henry NL, Ryden L, Kim C, Love RR, Schiff R, Rimm DL. Cytoplasmic estrogen receptor in breast cancer. Clin Cancer Res. 2012 Jan 1;18(1):118-26.
3. Lukinavičius G, Lavogina D, Gönczy P, Johnsson K. Commercial Cdk1 antibodies recognize the centrosomal protein Cep152. Biotechniques. 2013 Sep;55(3):111-4.
4. Couchman JR: Commercial antibodies: the good, bad, and really ugly. J HistochemCytochem. 2009; 57(1): 7–8. PubMed Abstract | Publisher Full Text | Free Full Text
5. Saper CB: An open letter to our readers on the use of antibodies. J Comp Neurol. 2005; 493(4): 477–8.PubMed Abstract | Publisher Full Text
6. Voskuil J: The troubles with commercial research antibodies dissected. Everest Biotech Blog. 2013